The term Cerebral Palsy (CP) is a set of neurological disorders that appear in infancy or early childhood and permanently affect body movement and muscle coordination. The prevalence of CP is two-three per 1000 births. Emerging rehabilitation therapies through new strategies are needed to diminish the assistance required for these patients, promoting their functional capability. This paper presents a new robotic platform called CPWalker for gait rehabilitation in patients with CP, which allows them to start experiencing autonomous locomotion through novel robot-based therapies. The platform (smart walker + exoskeleton) is controlled by a multimodal interface that gives high versatility. The therapeutic approach, as well as the details of the interactions may be defined through this interface. CPWalker concept aims to promote the earlier incorporation of patients with CP to the rehabilitation treatment and increases the level of intensity and frequency of the exercises. This will enable the maintenance of therapeutic methods on a daily basis, with the intention of leading to significant improvements in the treatment outcomes.
Introduction
1 Cerebral Palsy (CP) could be defined as a disorder that appears in infancy and 2 permanently affect posture and body movement but does not worsen over time [1] . CP 3 is often associated with sensory deficits, cognitive impairments, communication and 4 motor disabilities, behavior issues, seizure disorder, pain and secondary musculoskeletal 5 problems [1] . CP affects between two to three per 1000 live-births, reported to the 6 European registers by the Surveillance of Cerebral Palsy European Network (SCPE) 7
[2], and there is a prevalence of three to four per 1000 among school-age children in 8 USA [3] . 9
In some cases, the development of a secondary musculoskeletal pathology contributes 10 to loss of function, gait impairments, fatigue, activity limitations, and participation 11 restriction. Several technological advancements have been introduced into the field of 12 rehabilitation to complement conventional therapeutic interventions. Intense task-13 related strategies, comprehensive combination of non-invasive treatment, surgical 14 interventions and new technologies have been initiated to improve rehabilitation 15 strategies [4] . These novel technologies, such as robot-assisted gait training or other 16 computer-assisted systems have been primarily developed for adults [5] . Nevertheless, 17 after technological adaptations, these therapies have been implemented in the pediatric 18 field [6] . Preliminary results have supported the feasibility of these novel approaches in 19 the clinical context [7], [8] . More specifically, robot-based therapy is a safe treatment 20 option with no severe side effects [9] . In addition, clinical experience suggests that gait 21 training in children with considerable cognitive deficits could be conducted even more Traditionally, robotic strategies have been focused on the Peripheral Nervous System 24 (PNS) supporting patients to perform repetitive movements (a "Bottom-Up approach"). 25
However, CP primarily affects brain structures, and thus suggests that both PNS and 26
Central Nervous System (CNS) should be integrated into a physical and cognitive 27 rehabilitation therapy [10] . Current studies manifest that such integration of the CNS 28 into the human-robot loop maximizes the therapeutic effects, especially in children. 29
This approach is known as "Top-Down" approach [10] : motor patterns of the limbs are 30 represented in the cortex, transmitted to the limbs and feedback to the cortex. Although 31 this approach has been previously studied in other populations (e.g. stroke [11] , Spinal 32
Cord Injury [12] ), there is a lack of studies in Cerebral Palsy [13] . 33
On the other hand, rehabilitation with progressive reduction of partial body weight 34 support (PBWS) coinciding with over-ground walking encourages the patients and it is 35 a motivated condition for recovery in childhood [14] . 36
In this paper we propose a new robotic platform (CPWalker, Figure 1 ) with the aim of 37 supporting novel therapies following a "Top-Down" approach for CP rehabilitation. The 38 platform is composed by a smart walker with PBWS and autonomous locomotion for 39 free over-ground training, and a wearable robotic exoskeleton for joint motion support. 40
The interaction between the patients and the robotic device will take place through a 41
Multimodal Human-Robot Interface (MHRI) consisting in a set of sensors attached to 42 the device, allowing the users to control the system through different modalities that are 43 commented in the next points. We focus our attention on children with CP, who present 44 increased brain plasticity compared to adults, and are more likely to have a change in 45 motor patterns following an intervention [15] . With this platform we want to contribute 46 beyond reducing the clinician's effort or increasing the duration of the treatment, giving the novelties of: i) free movement (not restricted to treadmill training) to enhance the subject's motivation; ii) tailored therapies depending on the user's needs through Assist 49 as Needed (AAN) strategies to increase the patient's participation; iii) the use of 50 different sensors to improve the rehabilitation, controlling posture during robot-based 51 therapy; iv) integration of CNS to intensify the effects of the therapy. 52 
56
This paper presents the development of such a platform, which is called CPWalker. 57
Next section introduces the aspects related to the conceptual design of the platform and 58 the description of the different components of CPWalker. In section 3, the multimodal 59 interface to enable the implementations of "Top-Down" rehabilitation strategies is 60 presented. The elemental control strategies proposed for CPWalker are given in section 61 4. Section 5 discusses the control architecture and the communication between its 62 components. Preliminary technical validations are introduced in section 6. Finally, 63 section 7 reported the discussions and conclusions of the work.
Robotic platform
CPWalker is a robotic platform to help patients with CP (primarily children) to recover 66 the gait function through rehabilitation training. The definition of the conceptual design 67 of the platform was undertaken based on the results of several interviews with a 68 population composed by 4 children with CP, 10 relatives, 4 doctors and 5 69 physiotherapists. The evaluation of these results provided some requirements, features 70 and functionalities that were needed and should be integrated in the novel device. We 71 defined the neurophysiological aspects for the development of each subsystem: 72 anatomical joint and muscle groups target by our platform, as well as the kinematic and 73 kinetic profile patterns of pathological gait of subjects with PC. The result of this 74 analysis (Table I) enabled the consortium to: i) identify the needs and demands of gait 75 rehabilitation for different user's profiles; ii) recognize the problems and benefits 76 presented by the current walkers; iii) identify current gaps in the market; iv) determine 77 the features and functionality needed in the new walker; and v) determine the 78 requirements of accessibility and usability to be considered in the design and 79 development. 80 Based on this information we defined the conceptual design and the main requirements 83 of CPWalker platform. As a result, we decided to build our robotic platform based on 84 the commercially available device, NFWalker (Made For Movement, Norway). Some 85 mechanical modifications on the NFWalker were carried out in order to transform this 86 passive device into an active rehabilitation platform. The proposal of CPWalker 87 platform is similar to others adopted before [7], [14] , but in this case we intend to 88 design a fully active rehabilitation robotic platform, which will enable us to implement 89 robot-based therapies according to the "Top-Down" approach. As a result, CPWalker 90 will allow more intense exercises than passive devices. In order to do so, we 91 incorporated four active systems in both the walker and the exoskeleton: i) a drive 92 system of the platform; ii) a PBWS system; iii) an active system for the adaptation of 93 hip height; and iv) a system for controlling joint motion of the exoskeleton. These 94 systems will be described in depth in the following subsections. 95 This system is used to adapt the robotic platform to different anthropometric measures 143 by adjusting the hip joint of the exoskeleton at a specific distance from the ground with legs stretched. Therefore, the user can walk without restrictions. In order to 146 implement such actions, it is composed by the following actuators and sensors: 147  Actuators: this system is activated by a linear actuator E21BX300-U-001 148 (Bansbach easylift, Germany) composed by a hydraulic pump and two cylinder-149 pistons. The hydraulic pump is controlled by an electric motor. The pistons are 150 connected to the hip joint of the robot and by controlling its displacement the 151 system may control the height of the user's hip in relation to the ground ( Figure  152 4). With a stroke length of 300 mm, this actuator is able to generate forces high 153 enough to elevate the child. The cylinders work in parallel through a slideway 154 that supports the bending moments generated by the user's weight. 155
 Sensors: this system has one potentiometer for the height regulation system, 156 which is located in the docking between the exoskeleton and walker (Figure 4 ). 157
The potentiometer changes the measure according to the hip elevation with 158 respect to the walker platform. This parameter gives information about the 159 position of the hydraulic linear actuator. 160 lightweight and, at the same time, rigid and strong in order to allow walking and 170 increase strength and endurance of people with mobility disorders, in particular children 171 with CP. In order to make the robot compatible with different users, the length of the 172 structure can be adjusted to different patient's anthropometric measures. In addition, the 173 exoskeleton prevents displacements of lower limbs to abnormal positions. The device 174 has been designed for over-ground walking training, and according to this, the 175 maximum allowed range during walking is: 60º for hip flexion, 40º for hip extension, 176 90º for knee flexion and 0º for knee extension ( Several technologies are used to address these objectives, but in this case, the 223 interaction between the child and the robotic platform will take place through a MHRI 224 consisting of: i) an electroencephalographic (EEG) acquisition unit, used as a method to 225 take into account the patient's intention; ii) inertial measurement units (IMUs) to 226 improve the patient's postural control; and iii) a Laser Range Finder (LRF) to measure 227 the human locomotor patterns and to control the robotic platform accordingly. The 228 rationale of this multimodal interface is to allow integrated PNS and CNS into physical 229 and cognitive interventions. MHRI interaction with therapeutically selected tasks will 230 promote the re-organization of motor planning brain structures and thus, integrating 231 CNS into the therapy [10] . 232
EEG acquisition unit 233
Promoting the participation of CNS in the rehabilitation strategy implies knowing and 234 modulating the role of patients' brain activity depending of their motor capability. A 235 non-invasive way for achieving this is to capture the electrophysiological activity 236 related to motor behavior by EEG sensors placed along the patients' scalp. Based on 237 such signals, the aim is to build a brain computer interface for initiating the 238 rehabilitation therapy. Additionally, this system will enable to assess the changes The EEG control in CPWalker (Figure 1 ) is proposed as a method to begin the therapies 241 according to the patient's intention. The process carried out to integrate the EEG into the 242 MHRI comprises two stages: i) a first early phase aimed at remodeling cortical activity 243 related with gait; ii) a second phase where the subject controls actively the beginning of 244 the robot-based therapy on the CPWalker platform. In the first phase of training with 245 EEG, the child is lain on a bed and uses a pair of virtual reality glasses Oculus Rift 246 (Oculus, United States) through he/she can see a virtual environment in first person. 247
Once the subjects have trained with the virtual reality glasses and they dominate the 248 control of the EEG signals, they are prepared to implement this strategy into the robotic 249 platform. 250 information was a request of our clinical partners since it is a parameter of paramount 255 importance due to with IMUs-based interface we can report to therapists about therapy 256 progress and motor evolution of children with CP [24]- [26] . These exercises with IMUs 257 consist in giving acoustic feedback to the users when subject's trunk or head are not in a 258
IMUs sensors
proper position. The aim is to correct the patient's crouch gait and to achieve a better 259 extended hip position. 260
Laser Range Finder

261
The subsystem to detect the user's legs location in CPWalker is composed by a LRF 262 sensor URG-04LX (Hokuyo, Japan) that is able to scan 240º and the legs detection an algorithm calculates the position of the legs in real time. The sensor is installed on 265 the front of CPWalker at a height of 15 cm from the floor, in order to assess legs 266 movements. 267
The leg detection approach presented in this work combines techniques presented in 268 [27] , [28] , and it is split into four basic tasks: i) LRF data pre-processing; ii) transitions 269 detections; and iii) extraction of pattern and estimation of legs coordinates. In the pre-270 processing phase, the delimitations of the right leg zone and left leg zone are performed. This section describes the different lower-level controllers developed for the control of 289 basic functions of the robotic platform. These basic control strategies, in combination 290 with information provided by the multimodal interface and the different sensors 291 distributed along the platform, will support the implementation of various novel 292 therapies, which will be in accordance with the opinion of our clinical partners. Gait 293 training will be provided according to the level of disability while encouraging patient's 294 participation in the training process. CPWalker robot may use trajectory or impedance 295 control as the base of training therapies that will be developed in the future. These 296 strategies may be combined, selecting different subtasks of walking for each controller. 297
We expect that this possibility will improve the common rehabilitation, insomuch as the 298 therapy is more adapted to the subject's necessities. Moreover, we include a locomotion 299 strategy based on LRF sensor as novel concept of basic strategy. The LRF sensor will 300 work when zero-force control is selected in the exoskeleton. In this case, will be the 301 patient who controls the velocity of the translation through the movement of the lower 302 limbs. 303 
Trajectory control strategy
313
An important question for gait rehabilitation robots is how to assist the patient with the 314 minimum interaction forces between robot and human. This implies that subjects will 315 be able to walk more naturally maintaining the safety, stability and effectiveness of the 316 system. In order to achieve this, the gait pattern applied by the robotic device must be 317 adapted both to the individual user and to the characteristics of the gait. The reference 318 trajectories of CPWaker platform are generated according to the algorithm presented by 319 Koopman et al. in [32] , which reconstructs reference joints trajectories based on user's 320 height and gait speed. These reference trajectories consist of normal gait patterns 321 represented by joint angles (θref). The controller of each joint is responsible of ensuring 322 the guidance of its own motion in order to get a correct normal gait pattern in the whole 323 exoskeleton. As a result, the generated trajectory for CPWalker corresponds with a 324 matrix of three columns (hip, knee and ankle), while the rows are the angles along the 325 gait cycle (Equation 1). 326
With this simple strategy, the exoskeleton will be able to guide patient's lower limbs 328 following reconstructed normal reference trajectories for any given speed or percentage 329 of range of motion (ROM). An example of that is given in Figure 9 . 
362
Following this approach, the impedance control algorithm of CPWalker was set to 363 provide three levels of AAN: i) high impedance (more proximal to a pure trajectory 364 tracking); ii) medium impedance; and iii) low impedance (more proximal to patient in 365 charge mode). The relations between the extremes of impedance modes (high and low 366 modes) respect to the medium impedance were determined increasing and decreasing 367 around 50% the impedance parameters. Consequently, if the position controller is 368 higher, the torque controller must be reduced and vice versa. Figure 11 represents the 369 effects of each level of impedance for the same values of reference trajectory in hip 370 joint (red line) and force (blue line) measured in opposition and in favour of movement. 371
When a high level of impedance is applied, the real trajectory of the exoskeleton (green 372 line) follows in a better way the imposed reference (red line). This situation is closer to 373 trajectory tracking control. The opposite situation occurs with a low level of impedance, 374 since in this case, the patient is who has more participation in the control of CPWalker, 375 without becoming a total management of the device. 376 
380
Each exoskeleton joint has its own controller with specific parameters estimated 381 individually for each case and control mode, so the assistance may be generated 382 separately for each part of the exoskeleton. That means that the type of control may be 383 selected separately for each joint, but the tracking is ensured in all the exoskeleton 384 because the reference is sent for all the controllers in each cycle. This possibility 385 increases the modularity of the system. We defined the mean value of the distance of legs measured by the LRF sensor (d) as 396 the variable to be controlled. The control objective is to achieve a desired distance, (d = 397 dd), which is identified by the system when the user is placed on the platform. As a 398 result, ̃= − is defined as the control error, which represents legs motion at three 399 stages depending on its sign: i) when ̃ is close to zero, it represents a stable legs 400 position (double support, Figure 12 Finally, the control system is exponentially asymptotically stable, as it can be seen in 421 Equation 6. 422 ̃=̃( 0) · e −kt (6) Figure 12 also shows the ldd signal that represents the distance between both legs 423 produced by the difference between dl and dr (defined in Section 3.3). Such signal has a 424 sinusoidal evolution during walking, and it is useful to estimate human velocity (vh), 425
[37]. h v is obtained through the product of gait cadence estimation (ldd frequency) and 426 the estimation of step length (ldd amplitude estimation). This estimation is used as a 427 control input of the inverse kinematics controller previously defined. 428
Control Architecture
429
The control architecture of CPWalker is shown in Figure 13 . It intends to favor the 430 interaction of the whole platform. The control architecture is composed by four main 431 parts: 432 1) Robotic platform constituted by the exoskeleton and the smart walker with their 433 structure, sensors and actuators, as described in Section 2. 3) MHRI Remote computer runs the interaction of MHRI with the user. This computer is 445 able to acquire the information from the different sensors of the multimodal interface 446 (EEG, IMUs, LRF), process it and send the processed information to the control unit for 447 its implementation. This computer also allows the extraction of user parameters during 448 the therapy: identification of EEG patterns, locomotion pattern and interaction force 449 between the user and the device. It is also possible to save all the information retrieved 450 by the sensors for future offline analysis. 451 4) Clinician unit, which consists of a smartphone/tablet device, that executes an 452 application developed for the interface between the system and the doctor who is using 453 it. This clinical interface, monitors signals and tunes controller parameters in real time 454 during the control strategy execution. It has the following main objectives: i) 455 monitoring and validation of algorithms for CP rehabilitation; ii) data analysis 456 (statistics, algorithms performance, etc.); iii) storage of user information such as clinical 457 and anthropometrics data; and iv) comparison between different robot-based 458 rehabilitation therapies. 459 as, for every message received, each system has to return data information to the control 480 unit. Moreover, the control unit has a robust means to determine the integrity of the 481 network and the correct operation of the joint's actuators. If some failure occurs on the 482 network that cannot be corrected automatically (for instance, a cable disconnection), the 483 control unit instantly shuts down the robotic platform power and stops the CPWalker 484 platform for safety reasons. 485 detection of movement intention in patients with CP, which had not been properly 500 investigated before. According to Section 3.1, EEG unit has been introduced in the rehabilitation through CPWalker platform with the aim of integrating not only the PNS 502 but also the CNS into the rehabilitation therapies of children with CP. 503 A preliminary technical evaluation of the EEG system was done at Niño Jesús Hospital 504 with three children with CP, aged 11, 13 and 15 years respectively. All patients 505 presented no cognitive deficit and they started the first EEG session few days after 506 surgery. Considering that they were weak, we evaluated only the first phase presented in 507 projected in stereoscopic mode to the glasses for a more realistic experience. Each 520 session corresponds to a walk (in first person) through a defined path around the world. 521
Technical validation of the different systems
Along the path, there are different 22 obstacles (gates, stones, trees…). Each time the 522 patients got close to an obstacle, the walk stopped and they were instructed to relax for 523 3s, following a phase of walking imagination for other 3s. Then the obstacle disappears 524 and the walk slowly resumes. 525
From these sessions, we selected the pair (channel, frequency band) with the most 526 pronounced and longest decay of the EEG signals power or PSD (Power Spectral 527 Density) during the "obstacle disappearing" and "start walking" periods, with respect to 528 the resting periods. In the BCI-controlled sessions, an obstacle does not disappear until 529 the selected pair (channel, frequency band) reaches and keeps the learned power 530 associated to rest for 1s. Analogously, once the obstacle disappears, the walk is not re-531 started until the power value reaches the learned desynchronization for 1s. Each session 532 was performed after two weeks from the last one. 533
Preliminary results indicate that all patients were able to overcome all obstacles and 534 complete the paths after two sessions. The average time/frequency graphs of the best 535 channel for each patient are shown in Figure 14 (p < .05, with respect to "rest" period; 536 blue: lower PSD; red: higher PSD). These results demonstrate the ability of the EEG 537 system to control the start of the rehabilitation strategy, allowing the implementation of 538 the "Top-Down" approach proposed for this platform. Children with CP presented an altered gait pattern with an increased ROM of the trunk 545 during gait. This problem must be addressed as an independent movement limitation 546 and rehabilitation strategies must be oriented to correct it [41] . In order to address this 547 issue we developed a specific posture control therapy based on the CPWalker, that 548 provides feedback to the patients while allow they to move their legs. The rationale of 549 this IMUs based interface is to enhance the cognitive interaction between the child and 550 the robot. 551
Such this therapy was preliminarily evaluated in one child with spastic diplegia in order 552 to assess the usability of the system as a rehabilitation tool in clinical practice. The main 553 objective of this trial was oriented to assess the motor control improvements of the 554 trunk during gait. One IMU sensor was placed on the patient's head and the other on the 555 patient's chest. The exercises consisted on giving acoustic feedback to the user through 556 a disturbing sound when the subject's trunk or head were not in a proper position. At 557 the same time, the patient was walking with CPWalker following the position control 558 strategy. 559
In order to measure the progress of the subject after this robot-based therapy, trunk 560 kinematic data was obtained from 3D gait analysis before and after the experiment. The 561 data collection was performed using an eight infrared cameras system (BTS 562 BioEngeneering). Reflective markers were applied on the shoulder girdle (spinous 563 process of C7 and both acromio-clavicular joints). Marker trajectories were processed 564 and analyzed. For comparisons a pre-post graph was performed for this child (Figure  565   15 ). 
Validation of locomotion strategy based on LRF sensor 571
As a representative case, Figure 16 shows the control data recorded during an 572 experiment for 12 seconds; it corresponds to a patient with CP using the assistance of 573
CPWalker locomotion controller performing a straight path. Figure 16 .a shows the 574 distance of the legs obtained by the LRF data. ̃ is negative most of the time showing 575 that the patient is walking in forward direction as can be seen in Figure 16 .b. In Figure  576 16.c the control action vr(C), which is the CPWalker velocity command, follows (vh), as 577 expected. Finally, there is no significant delay between the control action, vr(C), and the 578 
584
In Figure 16 .a, it is possible to observe that the user decreased the step length from the 585 2 th to the 6 th second, and it was also increased form the 8 th to the 12 th seconds. These 586 changes are reflected in the human velocity estimation (vh) (see Figure 16 .c). 587
Consequently, both vr(C) and vr(R) are updated accordingly and the platform is able to 588 follow the user (see Figure 16 .c). 589
Although vh has the majority of the contribution in the control action (see Figure 16 .c), 590 there is also an oscillatory component. Such component is the contribution of ̃ to the 591 adjustment of the CPWalker motion during each step. Considering that the trunk is 592 fixed to the platform, when the user performs a step (swing phase), ̃ assumes a 593 negative value. Consequently, the control action is incremented to move the CPWalker reduced when the step is finished (double support). This strategy showed a natural 597 Human-CPWalker interaction during preliminary experiments. 598
Discussion and Conclusions
599
This paper has presented a novel robotic system for gait rehabilitation in children with 600 CP and similar motor disorders, which was developed in the framework of the project 601
CPWalker. The overall aim of this project is to develop a robotic platform to provide 602 means for testing new therapies for gait rehabilitation in subjects with CP. This paper 603 has been focused on the conceptualization, development and technical validation of this 604 robotic platform. 605
The robotic trainer integrates a robotic exoskeleton, a neuroprosthesis, and a smart 606 walker. The combination of these devices into the integrated platform enables the 607 therapists to implement novel interventions for gait training in CP. CPWalker is the first 608 trainer with dynamic bodyweight support and active driven gait in real environments. 609
CPWalker is equipped with kinematic and kinetic sensors. In addition, the interaction of 610 the user with the platform is implemented through a MHRI based on EEG, IMUs and 611 LRF sensors. These sensors will be also used to both provide a real-time biofeedback to 612 the children, and an off-line report to therapists and caregivers on therapy progress and 613 patient's motor evolution. Feedback information will be derived from the MHRI system, 614 e.g. trends in involuntary movements like effort during motor planning; and from robot 615 information, e.g. trajectories and driving time. The software tool developed to interface 616 the clinician with the robotic platform will allow the therapist to configure the 617 intervention and to obtain feedback of its outcome, both during the rehabilitation Results demonstrated that the different systems of the robotic platform are integrated 620 and performing. Preliminary results show the capacity of the novel robotic platform to 621 serve as a rehabilitation tool [8] . This platform will allow authors to precisely evaluate 622 the effects of different robot-based control strategies on population with CP. The 623 obtained outcomes with future clinical validations aim at providing important results to 624 understand and justify the use of robotic therapy. 625
This project is built on vast previous clinical evidence that neural plasticity is the central 626 core of motor development, and on studies suggesting that robot-mediated intensive 627 therapy is beneficial for improving functional recovery [42] . Nevertheless, current level 628 of evidence regarding the efficacy of new technologies in the rehabilitation process still 629 remains scarce. These approaches need to be refined and critically analyzed to 630 determine their functional benefit for children with different levels of sensory-motor, 631 cognitive impairment or both. 632
The presented platform enables the development of different therapies based on the 633 "Top-Down" approach. Future studies using the robotic platform are in place and 634 involve follow-up measurement to determine if gains will have long-term and lasting 635 impact for children with CP. 636
